JSKN003 trials for Breast cancer

All JSKN003 trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying JSKN003 for Breast cancer

• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
  NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer
  NCT06846437 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
  NCT06079983 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 87 locations

Common questions

How many trials study JSKN003 for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.